Join to View Full Profile
124 Tunbridge CirHaverford, PA 19041
Phone+1 484-868-8909
Fax+1 610-649-7522
Dr. Block is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gilbert Block is a neurologist in Haverford, PA. He received his MD degree and PhD from Case Western Reserve University School of Medicine. He has been on the faculty of New York Hopsital- Cornell University Medical Center and University of Pennsylvania. He is an adjunct professor of pharmacology and physiology at Drexel Universtiy School of Medicine. He has > 34 years of biotecn and pharmaceutical expereince focusing on development of drugs neurologic, psychiatric and rare diseases with expereince across all phases of drug development as well as preclinical translational models. He has been responsible for or payed a critical roll in 9 successful NDAs and WMAs. He has consulted for venture capital companies, big pharma, and biotech. He has been a consultant for the Gladstone Institutes and NCATS at NIH. He is currently the Chief Mecial Officer of both Altpep and Reset Pharmaceuticals.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1982 - 1985- New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1981 - 1982
Case Western Reserve University School of MedicineClass of 1981
Certifications & Licensure
PA State Medical License 1988 - 2000
Publications & Presentations
PubMed
- 68 citationsRandomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.Robert G. Miller, Gilbert Block, Jonathan S. Katz, Richard J. Barohn, Vidhya Gopalakrishnan
Neurology(R) Neuroimmunology & Neuroinflammation. 2015-06-01 - 312 citationsA randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.Leon J. Thal, Steven H. Ferris, Louis Kirby, G. Block, Christopher R. Lines
Neuropsychopharmacology. 2005-06-01 - 51 citationsValidation of a migraine work and productivity loss questionnaire for use in migraine studies.GM Davies, Nancy C. Santanello, William C. Gerth, D Lerner, G. Block
Cephalalgia. 1999-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
